High rates of sustained virological response in hepatitis C virus-infected injection drug users receiving directly observed therapy with peginterferon alpha-2a (40KD) (PEGASYS) and once-daily ribavirin (Q42996009)
Jump to navigation
Jump to search
scientific article published in April 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | High rates of sustained virological response in hepatitis C virus-infected injection drug users receiving directly observed therapy with peginterferon alpha-2a (40KD) (PEGASYS) and once-daily ribavirin |
scientific article published in April 2010 |
Statements
1 reference
High rates of sustained virological response in hepatitis C virus-infected injection drug users receiving directly observed therapy with peginterferon alpha-2a (40KD) (PEGASYS) and once-daily ribavirin (English)
1 reference
Michael Waizmann
1 reference
Grit Ackermann
1 reference
1 April 2010
1 reference
1 reference
38
1 reference
4
1 reference
338-345
1 reference
Identifiers
1 reference
1 reference